The E6 proteins from high-risk, cancer-causing types of human papillomavirus (HPV) are characterized by the presence of a PDZ (PSD95/Dlg/ZO-1) binding motif in their extreme carboxy termini, through which they interact with a number of cellular PDZ domain-containing substrates. In order to ascertain how many of these are degraded by E6 in vivo, we performed an extensive analysis of the effects of E6 ablation on the expression levels of a number of previously reported E6 PDZ substrates. Using HPV type 16 (HPV-16)-positive CaSKi cells and HPV-18-positive HeLa cells, we have found that MAGI-1 is a major degradation target of both HPV-16 and HPV-18 E6. In contrast, hDlg, hScrib, PTPN3, TIP2, FAP1, and PSD95 all exhibit various degrees of susceptibility to E6-induced degradation, and a high degree of HPV type specificity is observed for certain substrates. We also show that E6 preferentially targets MAGI-1 within the nucleus and at membrane sites. One of the direct consequences of MAGI-1 degradation is a loss of tight-junction integrity, as determined by mislocalization of the tight-junction protein ZO-1. Ablation of E6 expression restores tight junctions, and this restoration is dependent on the presence of MAGI-1. These results demonstrate that oncogenic HPV E6 proteins disrupt cellular tight junctions through the degradation of MAGI-1, and they provide further evidence of how the PDZ binding potential of E6 can contribute to HPV-induced malignancy.Human papillomaviruses (HPVs) are the causative agent of cervical cancer, which is brought about primarily by the combined action of two viral oncoproteins, E6 and E7 (reviewed in reference 55). These proteins target, respectively, the p53 (40, 50) and pRb (5, 9) tumor suppressors; they cooperate in the induction of keratinocyte immortalization (17, 33) and tumor formation in transgenic mice (14, 24); and they are required for the continued proliferation and survival of cervical-tumor-derived cell lines (21, 53). It is clear, however, that other cellular targets of both viral proteins are necessary for their full transforming activity. In the case of the high-risk HPV E6 oncoproteins, an interesting feature is the presence of a class 1 PDZ (PSD95/Dlg/ZO-1)-binding motif (PBM) at their carboxy termini (27), which is absent from E6 proteins derived from the low-risk HPV types. This PDZ binding potential renders these E6 proteins capable of interacting with, and potentially more importantly, targeting for proteasome-mediated degradation, a subset of PDZ domain-containing cellular substrates, including the cell polarity regulators human Dlg (hDlg) (11) and human Scribble (hScrib) (35), both of which are classified as potential tumor suppressor proteins (3, 6, 12, 37, 51, 52). Other E6 PDZ domain-containing targets include the MAGI family of proteins (13, 46), which are scaffolding molecules involved in the regulation of tight-junction (TJ) assembly (34). So far, at least 10 different PDZ domain-containing substrates of E6 have been described, including PSD95 (16), PATJ (25, ...